Boris Pasche MD PhD, FACP

Gastrointestinal Cancer

President & CEO, Karmanos Cancer Institute; Chair, Department of Oncology, Wayne State University; Comprehensive Cancer Center

Summary

Boris Pasche, MD, based in Detroit, MI, is an oncology specialist with a subspecialty in gastrointestinal cancer. He completed his fellowship in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center and holds significant experience in multiple types of cancer, including hepatocellular carcinoma and pancreatic cancer. Dr. Pasche serves as President & CEO of the Barbara Ann Karmanos Cancer Institute and chairs the Department of Oncology at Wayne State University School of Medicine. He has numerous publications in notable journals, focusing on cancer research and therapeutic strategies. His dedication to cancer research has been recognized with honors such as America's Top Doctors, the AACR Award in Metastatic Colon Cancer Research, and the Ohio State Cancer Genetics Medal.

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1994 - 2000
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1992 - 1994
Harvard Medical SchoolPost-Doctoral Fellowship, 1989 - 1992
Karolinska Institute Faculty of MedicineClass of 1989
University of LausanneM.D., 1980 - 1987

America's Top Doctors Castle Connolly, 2010-2025
America's Top Doctors for Cancer Castle Connolly, 2009-2025
Healthcare Hero Crain's Detroit, 2024
Elected Member The American Clinical and Climatological Association (ACCA), 2014
Jeannik M . Littlefield-AACR Award in Metastatic Colon Cancer Research AACR, 2006
The Ohio State University Human Cancer Genetics Program Commemorative Medal Ohio State University, 2005
Elected Fellow The American College of Physicians-The American Society of Internal Medicine, 2004
Traineed Investigator Award for Excellence in Scientific Research American Society for Clinical Investigation, 1992
Young Scientist Merit Award The International Society on Thrombosis and Hemostasis, 1989, 1991
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Elected Member The American Society for Clinical Investigation, 2007
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

PubMed

Journal Articles

Association of MUC16 Mutation with Tumor Mutation Load and Outcomes in Patients with Gastric Cancer
Boris Pasche, MD, JAMA

Wayne State University Celebrates Groundbreaking for $200 Million Health Sciences Research BuildingSeptember 9th, 2025
Access Health: Cancer Research's Golden Age Is on Shaky GroundMay 1st, 2025
U CAN-CER VIVE Gives $450K+ to Karmanos Cancer Institute for Continued Research in Using Radiofrequency to Treat CancerApril 23rd, 2025
Join now to see all

CANCER CENTER SUPPORT GRANTWAYNE STATE UNIVERSITY1997–2025
TGFBR1 Signaling In Colorectal CancerNational Cancer Institute2010–2012
Role Of Tgf-Beta Genetic Variants In The Pathogenesis Of SclerodermaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
Tgf-Beta Polymorphisms And Breast Cancer In FamiliesNational Cancer Institute2009–2011
Role Of Tgf-Beta Genetic Variants In The Pathogenesis Of SclerodermaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2010
Tgf-Beta Pathway Variants And Breast Cancer In FamiliesNational Cancer Institute2008
Tgf-Beta Pathway Polymorphisms And Colon Cancer RiskNational Cancer Institute2008
Tgf-Beta Pathway Polymorphisms And Colon Cancer RiskNational Cancer Institute2006–2008
Tgf-Beta Pathway Variants And Breast Cancer In FamiliesNational Cancer Institute2005–2008
Mutations Of The Type 1 TGF Beta Receptor In CancerNational Cancer Institute2001–2002
Type 1 TGF Beta Receptor AlterationsNational Cancer Institute2000–2001
Type 1 TGF Beta Receptor AlterationsNational Cancer Institute1999–2000
Comprehensive Cancer Center Core Support GrantNational Cancer InstitutePresent